A Japanese research team has successfully reproduced the human neural circuit in vitro using multi-region miniature organs known as assembloids, which are derived from induced pluripotent stem (iPS) ...

An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how—and where—the psychedelic compound rewires the connections in the brain.

Intel’s 386 CPU is notable for being its first x86 CPU to use so-called standard cell logic, which swapped the taping out of individual transistors with wiring up standardized functional blocks. This ...

No matter your current running pace and typical distance, in How to Run Faster, certified run coach Matt Meyer and other experts will help you speed up! You will learn crucial speed workouts, ...

The experimental model won't compete with the biggest and best, but it could tell us why they behave in weird ways—and how trustworthy they really are. ChatGPT maker OpenAI has built an experimental ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? When I started running more consistently a little over a year ago, I had a lot ...

Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...

Amkor Technology, Inc. is a key player in semiconductor packaging, recently beating EPS estimates and surging 84% since May, gets prior buy rating lowered a notch to a hold. AMKR benefits from strong ...

Trump rules out 2028 VP bid, won’t rule out third term Allies hint at plans to test two-term limit Trump praises Vance, Rubio as 'unstoppable' team ABOARD AIR FORCE ONE, Oct 27 (Reuters) - U.S.

Every day, your brain makes thousands of decisions under uncertainty. Most of the time, you guess right. When you don't, you learn. But when the brain's ability to judge context or assign meaning ...

Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to restore immune homeostasis. The New York-headquartered company was founded by a ...